There’s a growing list of rapid antigen tests reaching the market, but Roche’s closest competitor is Abbott, which launched two similar 15-minute nasal swab tests – called BinaxNOW in the US ...

The Roche Diagnostics Rapid Antigen Self-Test (RAT) kit was one of the first tests approved by the TGA for 'domestic' use in non-clinical settings to help suppress the spread of COVID-19. These kits ...

Diagnostics drive Q1 performance The news came as Roche recorded a 10% increase in first-quarter revenues to CHF 16.4 billion ($17.2 billion), on strong US demand for rapid COVID-19 antigen tests ...